Evidence map›Paper›PMID 33458899›Full record

ReviewCell proliferation2021

Exosomes from adipose-derived stem cells and application to skin wound healing.

Yang An, Shuyan Lin, Xiaojie Tan, Shiou Zhu, Fangfei Nie, Yonghuan Zhen, Luosha Gu, Chunlei Zhang, Baicheng Wang, Wei Wei and 2 more

Registry-linked trialAbstract readReview
In one paragraph

Review in Cell proliferation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06279039 (Clinical Observation of Exosomes in Patients After Q-switched Laser Surgery), which is not on this map. Cited by 271 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
271citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06279039 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Clinical Observation of Exosomes in Patients After Q-switched Laser Surgery

TypeinterventionalSponsorNanjing First Hospital, Nanjing Medical UniversityRan2022 to 2024Enrolled38ConditionsExosome, Skin Regeneration, LaserArmsExosome liquid dressing
3 · Its place in the literature

Who cites it

271 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

211 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yang AnDepartment of Plastic Surgery, Peking University Third Hospital, Beijing, China.ORCID https://orcid.org/0000-0003-3389-4832
Shuyan LinHearing Ctr, Department of Otolaryngology, Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China.
Xiaojie TanDepartment of Plastic Surgery, Peking University Third Hospital, Beijing, China.
Shiou ZhuState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Fangfei NieDepartment of Plastic Surgery, Peking University Third Hospital, Beijing, China.
Yonghuan ZhenDepartment of Plastic Surgery, Peking University Third Hospital, Beijing, China.
Luosha GuDepartment of Plastic Surgery, Peking University Third Hospital, Beijing, China.
Chunlei ZhangInstitute of Systems Biomedicine, Peking University, Beijing, China.
Baicheng WangDepartment of Plastic Surgery, Peking University Third Hospital, Beijing, China.
Wei WeiClinical Stem Cell Research Center, Peking University Third Hospital, Beijing, China.
Dong LiDepartment of Plastic Surgery, Peking University Third Hospital, Beijing, China.
Junhao WuHearing Ctr, Department of Otolaryngology, Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China.

Funding

Key Clinical Projects of Peking University Third Hospital BYSYZD2019013National Nature Science Foundation of China 81873939the Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Peking University Third Hospital BYSYLXHG2019001
6 · The paper itself

Abstract

Skin wound healing is an intractable problem that represents an urgent clinical need. To solve this problem, a large number of studies have focused on the use of exosomes (EXOs) derived from adipose-derived stem cells (ADSCs). This review describes the mechanisms whereby ADSCs-EXOs regulate wound healing and their clinical application. In the wound, ADSCs-EXOs modulate immune responses and inflammation. They also promote angiogenesis, accelerate proliferation and re-epithelization of skin cells, and regulate collagen remodelling which inhibits scar hyperplasia. Compared with ADSCs therapeutics, ADSCs-EXOs have highly stability and are easily stored. Additionally, they are not rejected by the immune system and have a homing effect and their dosage can be easily controlled. ADSCs-EXOs can improve fat grafting and promote wound healing in patients with diabetes mellitus. They can also act as a carrier and combined scaffold for treatment, leading to scarless cutaneous repair. Overall, ADSCs-EXOs have the potential to be used in the clinic to promote wound healing.

Indexed as

AdipocytesAnimalsExosomesHumansMesenchymal Stem CellsSkinStem CellsWound Healingadipose-derived stem cellsangiogenesisexosomesinflammationskin wound healing

Identifiers

PMID33458899
PMCPMC7941238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.